Sunshine Easy Company
Sunshine Easy Company headquartered in Houston, USA, has subsidiaries or offices in Beijing, Shanghai, Singapore and Hanoi in Asia, and Lisbon in Europe. It is engaged in international investment and financing, international market access consulting, import-export trade, market promotion and sales, production outsourcing, and global procurement services and others in the biopharmaceutical, medical device industries.
International investment and financing services: VC and PE investments, international incubation with equity holdings, financing consulting, investment matchmaking activities, and industrial park connection services
International market access consulting services: FDA agency services, international standard testing, QSR/cGMP declaration for medical device products, and medical device registration and clinical evaluation
Market promotion and sales: promoting and selling biopharmaceutical and medical device products in North American and Asian markets, establishing a global online sales system, and operating warehousing and logistics services in North America and Asia
Production outsourcing and global procurement services: process research and process validation of the products, original equipment manufacturing for pilot and post-market of the products; procurement and customized procurement services for medical devices and research experimental products
Meet Our Team
Mr. Wu has over 25 years of experience in investment and financing, marketing and sales, international market entry consultation, international procurement and contract manufacturing in the fields of biopharmaceuticals and medical devices. He has rich experience in international trade import and export, procurement and outsourcing, new product market expansion, and establishing offline and online distribution networks. Mr. Wu is the founder and president of Sunshine Easy Company, a US-based company, and the CFO of TomoWave (Suzhou) Medical Imaging Co., Ltd. in China. He also serves as the Chairman of the White Mountain Medical Foundation in the United States. He is an outstanding alumnus and alumni advisor of the Peking University School of Medicine and a member of the Leadership Committee of the Peking University School of Medicine-University of Michigan Medical School Joint Institute. Mr. Wu graduated from the Peking University School of Medicine with a bachelor's degree in clinical medicine in 1994 and from the Bauer Business School at the University of Houston with a master's degree in business administration in 2005.
Dr. Alexander, known as the "Father of International Biomedical Optoacoustic Imaging," has dedicated over 20 years to the research and industrial translation of biomedical optoacoustic imaging technology. He has received funding of nearly $20 million from institutions such as the National Institutes of Health (NIH) and has applied for 21 patents, including the world's first optoacoustic patent titled "Method and System for Optoacoustic Imaging." He has also published 11 monographs and over 200 research papers. He has been honored with the Berthold Leibinger Innovations Prize and the James Smith Award from the International Photoacoustic and Photothermal Association. Currently, Dr. Alexander serves as the CEO and CTO of TomoWave Laboratories, Inc., where he focuses on the development and commercialization of high-resolution, high-contrast, and high-sensitivity 3D optoacoustic tomography (OAT) technology for oncology and biology. He also holds the positions of CEO and General Manager at TomoWave (Suzhou) Medical Imaging Co., Ltd., an adjunct professor in the Department of Biomedical Engineering at the University of Houston and a Distinguished Professor of Medical Imaging at Guangzhou Medical University. Furthermore, Dr. Alexander has held various positions throughout his career, including being a board member and Chief Technology Officer (Vice President of Medical Technologies) at Seno Medical Instruments, Director of the Optoacoustic Imaging and Spectroscopy Laboratory at the Biomedical Engineering Center of the University of Texas Medical Branch at Galveston, adjunct assistant professor at the College of Optometry at the University of Houston, adjunct assistant professor in the Department of Electrical and Computer Engineering at Rice University, and the Santander Chair of Excellence in Electronics at Carlos III University of Madrid. Dr. Alexander graduated from the Moscow Engineering Physics Institute with a bachelor's degree in theoretical and experimental physics in 1978, from the Moscow Engineering Physics Institute with a master's degree in ultrafast laser spectroscopy of biomolecules in 1980, and from the Institute of Spectroscopy of the Soviet Academy of Sciences with a doctoral degree in spectroscopy, photochemistry, and biophysics in 1986.
Jianlin Song, M.D., J.D., graduated from the top medical school in Beijing, China, and began her professional life as a physician. Her education and work experience in medicine provide her with a solid background and extensive knowledge to represent companies and individual practitioners in the life sciences and health care industries after she entered the legal profession. During her 17-year legal career, Dr. Song has defended manufacturers of a very broad spectrum of life science products, from food supplements and dental adhesives to prescription drugs and medical devices. She also has represented clinical and diagnostic laboratories and medical, dental and nursing practitioners in professional malpractice cases and licensing disputes. In recent years she began representing assisted living facilities in elder abuse litigation. Dr. Song’s many successes include a number of reported no-liability judgments for medical device manufacturers and life science providers, a dismissal of a Dental Board accusation after 10 sessions of administrative hearing spanning over four months, and multiple successful settlements in cases with multimillion-dollar demands. In addition to her litigation practice, Dr. Song regularly advises domestic and international companies on FDA regulations, CLIA regulations and other regulations in the life sciences industries. She has been a frequent author and speaker on these issues.